Alignment Healthcare Inc.

NASDAQ: ALHC · Real-Time Price · USD
15.25
0.43 (2.90%)
At close: Aug 15, 2025, 2:56 PM

Alignment Healthcare Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
3.34B 3B 2.7B 2.47B 2.23B 2.01B 1.82B 1.72B 1.62B 1.53B 1.43B 1.37B 1.3B 1.25B 1.17B 1.11B 1.07B 1B
Cost of Revenue
2.93B 2.65B 2.41B 2.21B 1.99B 1.8B 1.62B 1.53B 1.45B 1.34B 1.25B 1.18B 1.12B 1.09B 1.04B 994.48M 930.57M 850.69M
Gross Profit
404.91M 347.34M 296.69M 257.97M 237.81M 213.57M 201.03M 189.21M 177.88M 185.35M 184.28M 187.17M 179.15M 154.51M 128.73M 117.42M 135.74M 150.98M
Operating Income
-24.71M -65.84M -101.56M -120.92M -131.16M -136.43M -127.82M -138.01M -141.66M -124.65M -128.64M -120M -128.04M -161.88M -178.07M -162.4M -105.89M -52.81M
Interest Income
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
-47.95M -90.81M -128.05M -144.25M -152.89M -157.4M -148.19M -157.76M -162.77M -145.85M -149.3M -140.31M -146.05M -179.23M -195.29M -179.52M -122.86M -69.73M
Net Income
-50.95M -90.63M -128.03M -144.15M -152.79M -157.25M -148.02M -157.8M -163M -146.11M -149.64M -140.48M -146.05M -179.23M -195.29M -179.52M -122.86M -69.73M
Selling & General & Admin
400.63M 384.69M 371.37M 352.98M 345.2M 327.54M 307.43M 306.92M 300.29M 291.76M 295.65M 290.5M 290.89M 300.37M 290.99M 264.03M 225.98M 188.53M
Research & Development
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Expenses
29M 28.49M 26.87M 25.91M 23.77M 22.47M 21.41M 20.3M 19.26M 18.24M 17.27M 16.67M 16.3M 16.03M 15.81M 15.8M 15.65M 15.27M
Operating Expenses
429.63M 413.18M 398.25M 378.89M 368.97M 350.01M 328.85M 327.22M 319.55M 310M 312.92M 307.17M 307.19M 316.4M 306.8M 279.82M 241.63M 203.79M
Interest Expense
20.33M 22.07M 23.55M 23.54M 22.07M 21.64M 21.23M 20.54M 19.68M 18.91M 18.29M 17.95M 17.76M 17.6M 17.44M 17.3M 17.16M 17.02M
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
3.36B 3.07B 2.81B 2.59B 2.36B 2.15B 1.95B 1.86B 1.77B 1.65B 1.56B 1.49B 1.43B 1.41B 1.35B 1.27B 1.17B 1.05B
Income Tax Expense
3.24M 42K 21K -10K -2K -23K -22K 174K 341K 340K 339K 167K n/a n/a n/a n/a n/a n/a
Shares Outstanding (Basic)
198.33M 193.61M 191.9M 191.36M 190.89M 189.01M 188.33M 187.33M 185.99M 183.11M 182.54M 182.12M 181.26M 178.87M 178.4M 177.83M 176.84M 154.43M
Shares Outstanding (Diluted)
209.52M 193.61M 191.9M 191.36M 190.89M 189.01M 188.33M 187.33M 185.99M 183.11M 182.54M 182.12M 181.26M 178.87M 178.4M 177.83M 176.84M 154.43M
EPS (Basic)
-0.27 -0.48 -0.68 -0.77 -0.82 -0.84 -0.79 -0.85 -0.88 -0.79 -0.82 -0.78 -0.82 -1.01 -1.15 -0.88 -0.55 -0.24
EPS (Diluted)
-0.28 -0.48 -0.68 -0.77 -0.82 -0.84 -0.79 -0.85 -0.88 -0.79 -0.82 -0.78 -0.82 -1.01 -1.15 -0.88 -0.55 -0.24
EBITDA
1.54M -40.08M -77.44M -94.59M -106.83M -113.05M -105.3M -116.67M -123.58M -108.47M -113.53M -105.48M -111.79M -145.4M -161.81M -146.18M -89.77M -37.13M
EBIT
-27.62M -68.74M -104.5M -120.71M -130.82M -135.76M -126.96M -137.22M -143.09M -126.95M -131.01M -122.36M -128.29M -161.63M -177.84M -162.22M -105.7M -52.71M
Depreciation & Amortization
29.16M 28.66M 27.06M 26.11M 23.99M 22.71M 21.67M 20.56M 19.51M 18.48M 17.49M 16.88M 16.5M 16.24M 16.03M 16.04M 15.93M 15.58M